Pembrolizumab in metastatic mismatch repair deficient colorectal cancer: the beginning of a journey into the land of immunotherapies for all cancers
@article{CCO103542,
author = {Axel Grothey},
title = {Pembrolizumab in metastatic mismatch repair deficient colorectal cancer: the beginning of a journey into the land of immunotherapies for all cancers},
journal = {Chinese Clinical Oncology},
volume = {11},
number = {5},
year = {2022},
keywords = {},
abstract = {},
issn = {2304-3873}, url = {https://cco.amegroups.org/article/view/103542}
}